Abstract
In the study of inflammatory mechanisms in the upper respiratory tract, the unknown dilution of collected samples of nasal secretions poses a serious problem for interpretation of the measured concentrations of various substances in the specimens. We investigated the magnitude of the dilution problem in a true clinical research situation and determined the validity of using the levels of total protein, albumin, and secretory IgA in nasal secretions to correct for the unknown dilution. The study samples consisted of simultaneously obtained nasopharyngeal aspirates and nasal lavage specimens from 52 children with upper respiratory tract infection. The dilution factors of the nasal lavage specimens varied widely between 1.8 and 432 (median, 11.2). Of the three proteins studied, total protein had the narrowest intersubject variation in the nasal secretions of the children and thus seemed to provide the best standardization method for comparing levels of substances between individuals. Concentrations of IL-6 standardized with total protein correlated significantly better with the true IL-6 concentrations in the nasal secretions than did IL-6 levels measured in the nasal lavage specimens without standardization (p = 0.049). These findings suggest that the most common current practice of measuring substances in nasopharyngeal specimens, i.e. measuring without correction for the dilution, may produce "false-negative" results. Potentially important information on inflammatory mechanisms may be undetected if false-negative results mask real differences between groups. The use of exogenous markers of dilution might improve the accuracy of quantifying substances in nasal secretions.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- URI:
-
upper respiratory tract infection
- sIgA:
-
secretory IgA
- CI:
-
confidence interval
References
Monto AS, Ullman BM 1974 Acute respiratory illness in an American community: the Tecumseh study. JAMA 227: 164–169
Ruuskanen O, Arola M, Putto-Laurila A, Mertsola J, Meurman O, Viljanen MK, Halonen P 1989 Acute otitis media and respiratory virus infections. Pediatr Infect Dis J 8: 94–99.
Igarashi Y, Skoner DP, Doyle WJ, White MV, Fireman P, Kaliner MA 1993 Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J Allergy Clin Immunol 92: 722–731.
Murphy BR, Graham BS, Prince GA, Walsh EE, Chanock RM, Karzon DT, Wright PF 1986 Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol 23: 1009–1014
Gustafson LM, Proud D, Hendley JO, Hayden FG, Gwaltney JM Jr 1996 Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 97: 1009–1014
Linden M, Greiff L, Andersson M, Svensson C, Åkerlund A, Bende M, Andersson E, Persson CGA 1995 Nasal cytokines in common cold and allergic rhinitis. Clin Exp Allergy 25: 166–172
Doyle WJ, Skoner DP, White M, Hayden F, Kaplan AP, Kaliner MA, Shibayama Y, Fireman P 1996 Pattern of nasal secretions during experimental influenza virus infection. Rhinology 34: 2–8
Röseler S, Holtappels G, Wagenmann M, Bachert C 1995 Elevated levels of interleukins IL-1β, IL-6 and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolaryngol 252 ( suppl 1): 61–63
Neuzil KM, Graham BS 1996 Cytokine release and innate immunity in respiratory viral infection. Semin Virol 7: 255–264
Grünberg K, Timmers MC, Smits HH, de Klerk EPA, Dick EC, Spaan WJM, Hiemstra PS, Sterk PJ 1997 Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy 27: 36–45
Chonmaitree T, Lett-Brown MA 1992 Variations in histamine, IgE and interferon concentrations in nasal secretions an sera of children with asthma associated with viral or mycoplasma infection. Pediatr Allergy Immunol 3: 16–22
Welliver RC, Wong DT, Sun M, Middleton E Jr, Vaughan RS, Ogra PL 1981 The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 305: 841–846
Matsuda K, Tsutsumi H, Okamoto Y, Chiba C 1995 Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin Diagn Immunol 2: 322–324
Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, Koren HS, Becker S 1995 Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 171: 584–592
Sigurs N, Bjarnason R, Sigurbergsson F 1994 Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy. Acta Paediatr 83: 1151–1155
Turner RB, Weingand KW, Yeh C-H, Leedy DW 1998 Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis 26: 840–846
Bisgaard H, Krogsgaard OW, Mygind N 1987 Measurement of secretion in nasal lavage. Clin Sci 73: 217–222
Balfour-Lynn 1 1996 Importance of using markers of dilution when measuring inflammatory mediators in nasal lavage fluid. [letter] J Infect Dis 173:1049
Owen MJ, Hornberger B, Pohl JF, Chonmaitree T, Howie VM 1996 Bacteriologic and clinical efficacy of ceftriaxone in the treatment of acute otitis media. In: Lim DJ, Bluestone CD, Casselbrant M, Klein JO, Ogra PL (eds) Recent Advances in Otitis Media. BC Decker, Hamilton, Ontario, 238–241.
Hall CB, Douglas RG Jr 1975 Clinically useful method for the isolation of respiratory syncytial virus. J Infect Dis 131: 1–5
Chonmaitree T, Patel JA, Garofalo R, Uchida T, Sim T, Owen MJ, Howie VM 1996 Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media. Ann Otol Rhinol Laryngol 105: 968–974
Bakos M-A, Kurosky A, Woodard CS, Denney RM, Goldblum RM 1991 Probing the topography of free and polymeric Ig-bound human secretory component with monoclonal antibodies. J Immunol 146: 162–168
Steel RGD, Torrie JH 1960 Principles and Procedures of Statistics. McGraw-Hill Book Company, New York, 183–193.
Kaulbach HC, White MV, Igarashi Y, Hahn BK, Kaliner MA 1993 Estimation of nasal epithelial lining fluid urea as a marker. J Allergy Clin Immunol 92: 457–465
Marcy TW, Merrill WW, Rankin JA, Reynolds HY 1987 Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage. Am Rev Respir Dis 135: 1276–1280
Linder A, Ronquist G, Deuschl H 1983 Random distribution of exogenous lithium in nasal secretion and its application in substance determination. Acta Otolaryngol 96: 287–293
Virolainen A, Mäkelä MJ, Esko E, Jero J, Alfthan G, Sundvall J, Leinonen M 1993 New method to assess dilution of secretions for immunological and microbiological assays. J Clin Microbiol 31: 1382–1384
Acknowledgements
The authors thank Constance Baldwin, Ph.D., for reviewing and editing the manuscript.
Author information
Authors and Affiliations
Additional information
Supported by National Institutes of Health Grant R01 DC 02620; the Academy of Finland; and the Maud Kuistila Memorial Foundation, Finland. Dr. Heikkinen is a recipient of a European Society for Paediatric Infectious Diseases Fellowship Award sponsored by Bristol-Myers Squibb.
Rights and permissions
About this article
Cite this article
Heikkinen, T., Shenoy, M., Goldblum, R. et al. Quantification of Cytokines and Inflammatory Mediators in Samples of Nasopharyngeal Secretions with Unknown Dilution. Pediatr Res 45, 230–234 (1999). https://doi.org/10.1203/00006450-199902000-00012
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199902000-00012
